Association between the acquisition of antibodies against Lyme disease and the risk of atrial arrhythmias.

Autor:	Hasiec A; 1st Department of Heart Rhythm Disorders, National Institute of Cardiology, Warsaw, Poland. andrzejhasiec@gmail.com, Wolny R; Department of Interventional Cardiology and Angiology, National Institute of Cardiology, Warsaw, Poland, Duda B; 1st Department of Heart Rhythm Disorders, National Institute of Cardiology, Warsaw, Poland, Warmiński G; 1st Department of Heart Rhythm Disorders, National Institute of Cardiology, Warsaw, Poland, Kowalik I; National Institute of Cardiology, Warsaw, Poland, Walczak E; National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland, Bilińska M; 1st Department of Heart Rhythm Disorders, National Institute of Cardiology, Warsaw, Poland, Urbanek P; 1st Department of Heart Rhythm Disorders, National Institute of Cardiology, Warsaw, Poland, Bodalski R; 1st Department of Heart Rhythm Disorders, National Institute of Cardiology, Warsaw, Poland, Orczykowski M; 1st Department of Heart Rhythm Disorders, National Institute of Cardiology, Warsaw, Poland, Sterliński M; 1st Department of Heart Rhythm Disorders, National Institute of Cardiology, Warsaw, Poland, Szumowski Ł; 1st Department of Heart Rhythm Disorders, National Institute of Cardiology, Warsaw, Poland
Jazyk:	angličtina
Zdroj:	Polish archives of internal medicine [Pol Arch Intern Med] 2022 May 30; Vol. 132 (5). Date of Electronic Publication: 2022 Jan 28.
DOI:	10.20452/pamw.16201
Abstrakt:	Introduction: The impact of antibodies against Borrelia burgdorferi (BB) on the occurrence of cardiac arrhythmias in patients without typical symptoms of Lyme disease (LD) is largely unknown. Objectives: We aimed to assess the risk of atrial fibrillation (AF) and other atrial arrhythmias (AAs) in patients who tested positive for anti-LD antibodies. Patients and Methods: We included consecutive patients referred for the diagnosis and treatment of AAs who had no history of erythema migrans or other symptoms of LD. The presence of anti-BB antibodies (immunoglobulin [Ig] M and IgG) was assessed in each patient, and the diagnostic workup of cardiac arrhythmias was performed. Results: Of the 527 patients enrolled in the study, 292 (55%) were diagnosed with AAs, and we detected BB antibodies in 131 individuals (24.8%). The patients with a serological history of Borrelia infection were older (mean [SD], 55.6 [15.7] vs 50.3 [18.6] years; P = 0.01), had a higher probability of developing AF or other supraventricular arrhythmias (SAs) (66.4% vs 51.8%; P = 0.03), and had elevated levels of N‑terminal pro-B ‑type natriuretic peptide (NT‑proBNP) (58% vs 47.5%; P = 0.04). We also found an as-sociation between the occurrence of AF and other SAs in patients with anti-BB antibodies and elevated NT‑proBNP values, and the risk of AAs in these patients increased almost 3‑fold (P = 0.01). Conclusion: Our data indicated an association between the exposure to Borrelia infection and the risk for AF and other AAs in the patients with elevated levels of NT‑proBNP, suggesting the need for a more efficacious diagnostic approach to patients with SAs, especially in LD‑endemic regions.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu